Boston ScientificBSX
About: Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Employees: 48,000
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
82% more first-time investments, than exits
New positions opened: 162 | Existing positions closed: 89
18% more repeat investments, than reductions
Existing positions increased: 552 | Existing positions reduced: 467
6% more funds holding
Funds holding: 1,290 [Q2] → 1,363 (+73) [Q3]
6% more capital invested
Capital invested by funds: $103B [Q2] → $109B (+$5.7B) [Q3]
3% less funds holding in top 10
Funds holding in top 10: 36 [Q2] → 35 (-1) [Q3]
3.02% less ownership
Funds ownership: 91.45% [Q2] → 88.42% (-3.02%) [Q3]
30% less call options, than puts
Call options by funds: $661M | Put options by funds: $944M
Research analyst outlook
14 Wall Street Analysts provided 1 year price targets over the past 3 months
14 analyst ratings
Truist Securities Richard Newitter 79% 1-year accuracy 33 / 42 met price target | 24%upside $110 | Buy Maintained | 18 Dec 2024 |
JP Morgan Robbie Marcus 48% 1-year accuracy 10 / 21 met price target | 24%upside $110 | Overweight Maintained | 16 Dec 2024 |
TD Cowen Joshua Jennings 42% 1-year accuracy 8 / 19 met price target | 24%upside $110 | Buy Maintained | 12 Dec 2024 |
Citigroup Joanne Wuensch 55% 1-year accuracy 26 / 47 met price target | 20%upside $107 | Buy Maintained | 11 Dec 2024 |
Wells Fargo Larry Biegelsen 51% 1-year accuracy 24 / 47 met price target | 12%upside $100 | Overweight Maintained | 11 Dec 2024 |
Financial journalist opinion
Based on 15 articles about BSX published over the past 30 days
